Pinsent Masons advises SPE Capital in the sale of Amanys Pharma to Laprophan

This transaction constitutes the second exit for SPE AIF, the USD 260m African-focused fund managed by SPE Capital and which reached final close December 2020. Laprophan and Amanys aim to form a diversified pharmaceutical group in Morocco and Africa, built around specialised and complementary businesses.

The Pinsent Masons Luxembourg team advising on the transaction was led by Tax and Corporate Partner David Maria, with the assistance of Corporate Legal Director Luís Marques Guilherme, Tax Senior Associate Stephanie Raffini and Junior Associate Randula Mihidukulasuriya.

Commenting on this key matter, David Maria said: “We are proud to have supported our long-term client SPE Capital in facilitating this strategic transaction for Morocco and the broader African continent. This synergy is set to advance the healthcare sector and fulfil the region’s increasing needs”.